Johnson Matthey PLC (LON:JMAT – Get Free Report) hit a new 52-week low on Friday . The company traded as low as GBX 1,312 ($16.30) and last traded at GBX 1,315.29 ($16.34), with a volume of 1451411 shares. The stock had previously closed at GBX 1,337 ($16.61).
Analyst Ratings Changes
JMAT has been the subject of a number of research reports. Berenberg Bank dropped their target price on Johnson Matthey from GBX 1,650 ($20.50) to GBX 1,500 ($18.63) and set a “hold” rating for the company in a report on Thursday, November 28th. Jefferies Financial Group restated a “buy” rating and set a GBX 1,800 ($22.36) target price on shares of Johnson Matthey in a research note on Tuesday, December 17th.
Read Our Latest Research Report on JMAT
Johnson Matthey Trading Down 1.6 %
Johnson Matthey Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Tuesday, February 4th. Investors of record on Thursday, December 5th will be given a dividend of GBX 22 ($0.27) per share. The ex-dividend date of this dividend is Thursday, December 5th. This represents a yield of 1.47%. Johnson Matthey’s dividend payout ratio is currently 13,275.86%.
Insiders Place Their Bets
In related news, insider Liam Condon bought 27 shares of the stock in a transaction that occurred on Wednesday, October 16th. The stock was acquired at an average cost of GBX 1,505 ($18.70) per share, with a total value of £406.35 ($504.78). Also, insider Stephen Oxley bought 7,407 shares of the business’s stock in a transaction on Wednesday, November 27th. The shares were bought at an average cost of GBX 1,343 ($16.68) per share, for a total transaction of £99,476.01 ($123,572.68). Insiders bought a total of 7,458 shares of company stock valued at $10,024,332 in the last 90 days. Corporate insiders own 0.61% of the company’s stock.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
- Five stocks we like better than Johnson Matthey
- ETF Screener: Uses and Step-by-Step Guide
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Buy P&G Now, Before It Sets A New All-Time High
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Most active stocks: Dollar volume vs share volume
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.